Givaudan, CH0010645932

Givaudan stock heads into October 13 results with a 4.6 percent view

Published on 10/07/2026 at 13:17 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Givaudan stock was last at CHF 3,380 on October 7, 2026, while Barclays lifted its target to CHF 3,850 on October 5. First-half net income fell to CHF 475.0 million.

A clean overhead flatlay on natural linen fabric. Anonymous clear glass bottles of varying shapes, all plain and unlabelled, are arranged across the frame. Scattered around them are raw aromatic ingredients: split vanilla pods, pink rose petals, curled ci
Givaudan CH0010645932 Flatlay mit anonymen Glasflakons, Vanilleschoten, Rosenblüten und Zitrusschalen auf Leinen, Illustration mit AI erstellt.

Givaudan (ISIN CH0010645932) was last at CHF 3,380 on SIX on October 7, 2026, at 1:01 p.m. CEST, down 0.65 percent from the prior close. The fragrance and flavor maker now approaches its third-quarter results date of October 13, 2026, a checkpoint that could test the recovery case built into recent analyst upgrades.

October 13 brings the next test

As Yahoo Finance reported on October 5, 2026, Givaudan is scheduled to report third-quarter results on October 13. Barclays forecasts group organic sales growth of 5.6 percent in the third quarter, 6.1 percent in the fourth quarter and 4.6 percent for 2026.

The upcoming release matters because the latest reported interim numbers were weaker. Simply Wall St reported first-half 2026 revenue of CHF 3.80 billion, down 1.7 percent from the first half of 2025, while net income declined 20 percent to CHF 475.0 million.

Margins remain the key counterweight

First-half adjusted? No. The reported earnings-per-share figure was CHF 51.46, compared with CHF 64.18 a year earlier, according to Simply Wall St. That 19.8 percent decline gives the October release a clear operational hurdle: stronger organic sales must begin to translate into earnings recovery.

Barclays upgraded Givaudan from Equal Weight to Overweight on October 5 and raised its price target from CHF 3,450 to CHF 3,850, as Markets Insider reported. The bank cited improving prospects in Taste and Wellbeing and easing concerns about Fine Fragrance market share.

Consensus stays below the market

The broader analyst view is less optimistic than Barclays. Markets Insider reported a Hold consensus and an average price target of CHF 3,272.67 on October 6, 2026. The gap between the bullish Barclays view and the wider consensus leaves the October 13 revenue and margin figures as the next concrete test of the recovery narrative.

Givaudan stock stays below its yearly high

Givaudan stock was last at CHF 3,380 on SIX on October 7, 2026, at 1:01 p.m. CEST. The 52-week range was CHF 2,566 to CHF 3,592, placing the latest quote CHF 212 below the high and CHF 814 above the low.

Givaudan stock facts

  • Company: Givaudan S.A.
  • ISIN: CH0010645932
  • WKN: 938427
  • Ticker: GIVN
  • Trading venue: SIX
  • Price (as of October 7, 2026, 1:01 p.m. CEST): CHF 3,380
  • Market capitalization: CHF 31.2 billion (as of October 7, 2026)
  • 52-week range: CHF 2,566-3,592 (as of October 7, 2026)
  • Sector / Industry: Materials / Specialty Chemicals
  • Index membership: SMI, SPI, SLI

Upcoming dates for Givaudan stock

  • October 13, 2026: Third-quarter results

More news and analyses on Givaudan stock

Disclaimer...

en | CH0010645932 | GIVAUDAN | boerse | 70254991 | bgmi